Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
22nd Annual Women’s Health Annual Visit (WHAV)
Multiple dates & locations available
Shared Goals, Shared Gains: Align With Patient Preferences
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Escalate With Intention: Stepwise, Target-Anchored Moves
The 2-Point Signal: Apply ≥2-Point Rule
When to Begin FcRn: Initiation Criteria, Key Evidence
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Turning Flares Into Function: Flag Uncontrolled Disease
The IgG Clock: Redose Using IgG Kinetics
Minimal By Design: Define MSE Endpoints
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Target Locked in gMG: Why T2T Matters
Pre- and Postoperative Use of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Linda Bradley, MD
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Samantha Denäe
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Melissa Simon, MD
Casey Joe Hinds
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.